Syncona Portfolio Ltd 13D and 13G filings for Autolus Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 1:44 pm Sale |
2023-12-31 | 13G | Autolus Therapeutics plc AUTL |
Syncona Portfolio Ltd | 30,734,957 11.600% |
-2,792,205 (-8.33%) |
Filing |
| 2024-02-13 6:41 pm Unchanged |
2023-12-31 | 13G | Autolus Therapeutics plc AUTL |
Syncona Portfolio Ltd | 33,527,162 14.400% |
0 (Unchanged) |
Filing |
| 2023-02-14 10:28 am Purchase |
2022-12-31 | 13G | Autolus Therapeutics plc AUTL |
Syncona Portfolio Ltd | 33,527,162 19.700% |
14,000,000 (+71.70%) |
Filing |
| 2022-02-11 12:21 pm Purchase |
2021-12-31 | 13G | Autolus Therapeutics plc AUTL |
Syncona Portfolio Ltd | 19,527,162 26.800% |
3,571,428 (+22.38%) |
Filing |
| 2021-02-12 10:43 am Purchase |
2020-12-31 | 13G | Autolus Therapeutics plc AUTL |
Syncona Portfolio Ltd | 15,955,734 30.500% |
1,363,636 (+9.35%) |
Filing |